The American College of Physicians (ACP) considered evidence for the comparative effectiveness and safety of oral type 2 diabetes drugs to develop guidelines for the use of these agents. The ACP recommends that clinicians prescribe an oral drug for patients diagnosed with type 2 diabetes when diet and exercise fail to adequately control hyperglycemia, use monotherapy with metformin as first-line oral therapy unless contraindications exist, and add a second drug to metformin therapy when monotherapy fails. The ACP found no strong evidence to support that one class of drug is better than another as a second drug.
Topics:
pharmacotherapy, metformin, diabetes mellitus, type 2, sulfonylurea compounds, thiazolidinedione, clinical practice guideline, ...
Ann Intern Med. 2012;156(3):218-231. doi:10.7326/0003-4819-156-3-201202070-00011